| Symbol |
KIF15 |
| Full Name |
Kinesin Family Member 15 |
| Chromosome |
3p21.31 |
| NCBI Gene |
56992 |
| Ensembl |
ENSG00000163808 |
| UniProt |
Q9Y5D2 |
| Diseases |
[Parkinson's Disease](/diseases/parkinsons-disease) |
| Expression |
Cerebral [cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus), Testis, Proliferating cells |
KIF15 (Kinesin Family Member 15), also known as TKLP1 (Tubulin Kinesin-Like Protein 1), is a gene located on chromosome 3p21.31 that encodes a plus-end-directed kinesin motor protein. KIF15 is a unique mitotic kinesin that functions independently of the canonical Eg5 (KIF11) pathway for spindle assembly. Rare variants in KIF15 have been associated with Parkinson's disease, suggesting potential roles in neuronal survival and axonal transport.
| Property |
Value |
| Location |
3p21.31 |
| Protein |
KIF15 (1798 aa) |
| Molecular weight |
~200 kDa |
| Primary function |
Mitotic spindle assembly, chromosome segregation |
¶ Mitosis and Cell Division
KIF15 is a bipolar kinesin motor protein critical for mitotic spindle assembly:
- Spindle pole separation: Promotes spindle pole separation during prophase and prometaphase
- Chromosome congression: Helps align chromosomes at the metaphase plate
- Kinetochore-microtubule attachments: Stabilizes kinetochore-microtubule attachments
- Redundant pathways: Functions redundantly with Eg5 (KIF11) to ensure proper spindle formation
¶ Motor Domain and Mechanism
- N-terminal motor domain: Contains microtubule-binding and ATPase activity
- Coiled-coil domains: Mediate dimerization and cargo binding
- Tail domain: Regulates motor activity and targeting
- Plus-end directed: Moves toward microtubule plus ends (fast-growing ends)
In neurons, kinesin motors are essential for:
- Axonal transport: Bidirectional transport of vesicles, organelles, and protein complexes
- Synaptic vesicle delivery: Transport of synaptic components to nerve terminals
- Mitochondrial distribution: Mitochondrial trafficking along axons
- Protein quality control: Transport of misfolded proteins to degradation sites
KIF15 variants have been implicated in PD risk:
- Genetic association: Rare coding variants in KIF15 identified in PD patients in exome sequencing studies
- Potential mechanisms:
- Impaired axonal transport leading to accumulation of damaged proteins
- Mitochondrial trafficking defects in dopaminergic neurons
- Altered cell cycle regulation in neurons
KIF15 is frequently overexpressed in cancers:
- Proliferation: Supports rapid cancer cell division
- Therapeutic target: KIF15 inhibitors are being explored as anticancer agents
- Chemotherapy resistance: May contribute to taxane resistance in some cancers
- Charcot-Marie-Tooth disease: Potential involvement of axonal transport genes
- Alzheimer's disease: Kinesin dysfunction is a common feature
- Centrosomal proteins: Localizes to spindle poles during mitosis
- Tubulin heterodimers: Binds and hydrolyzes ATP for movement
- Kinesin light chains: May associate with cargo adapter proteins
- Cell cycle regulators: CDK1-mediated phosphorylation controls mitotic function
- Aurora kinases: Phosphorylation regulates spindle checkpoint
- MAPK pathway: Potential crosstalk with neuronal survival signaling
- KIF15 inhibitors: Several small molecules targeting KIF15 are in development
- Combination therapy: Potential synergy with taxanes and other microtubule-targeting agents
- Axonal transport enhancement: Strategies to improve kinesin function
- Gene therapy: Viral vector-mediated KIF15 expression modulation
The study of Kif15 Gene Kinesin Family Member 15 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.